01 1Aurobindo Pharma Limited
01 1DEFERASIROX
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-10-16
Pay. Date : 2019-09-26
DMF Number : 34191
Submission : 2019-09-26
Status : Active
Type : II
20
Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DEFERASIROX, with a corresponding US DMF Number 34191.
Remarkably, this DMF maintains an Active status since its submission on September 26, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 16, 2019, and payment made on September 26, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
